List of Tables
    Table 1. Novel Antiviral Drugs Market Opportunities & Trends in Global Market
    Table 2. Novel Antiviral Drugs Market Drivers in Global Market
    Table 3. Novel Antiviral Drugs Market Restraints in Global Market
    Table 4. Key Players of Novel Antiviral Drugs in Global Market
    Table 5. Top Novel Antiviral Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Novel Antiviral Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Novel Antiviral Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Novel Antiviral Drugs Product Type
    Table 9. List of Global Tier 1 Novel Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Novel Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Novel Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Novel Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Novel Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Novel Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Novel Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Novel Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Novel Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Novel Antiviral Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Novel Antiviral Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Novel Antiviral Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Novel Antiviral Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Novel Antiviral Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Novel Antiviral Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Novel Antiviral Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Holding AG Corporate Summary
    Table 31. Roche Holding AG Novel Antiviral Drugs Product Offerings
    Table 32. Roche Holding AG Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. GlaxoSmithKline Corporate Summary
    Table 34. GlaxoSmithKline Novel Antiviral Drugs Product Offerings
    Table 35. GlaxoSmithKline Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Bristol-Myers Squibb Corporate Summary
    Table 37. Bristol-Myers Squibb Novel Antiviral Drugs Product Offerings
    Table 38. Bristol-Myers Squibb Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. AbbVie Corporate Summary
    Table 40. AbbVie Novel Antiviral Drugs Product Offerings
    Table 41. AbbVie Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Johnson & Johnson Corporate Summary
    Table 43. Johnson & Johnson Novel Antiviral Drugs Product Offerings
    Table 44. Johnson & Johnson Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Merck & Co Corporate Summary
    Table 46. Merck & Co Novel Antiviral Drugs Product Offerings
    Table 47. Merck & Co Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis Corporate Summary
    Table 49. Novartis Novel Antiviral Drugs Product Offerings
    Table 50. Novartis Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Dr Reddy’s Corporate Summary
    Table 52. Dr Reddy’s Novel Antiviral Drugs Product Offerings
    Table 53. Dr Reddy’s Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Gilead Sciences Corporate Summary
    Table 55. Gilead Sciences Novel Antiviral Drugs Product Offerings
    Table 56. Gilead Sciences Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Aurobindo Pharma Corporate Summary
    Table 58. Aurobindo Pharma Novel Antiviral Drugs Product Offerings
    Table 59. Aurobindo Pharma Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Cipla Corporate Summary
    Table 61. Cipla Novel Antiviral Drugs Product Offerings
    Table 62. Cipla Novel Antiviral Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Novel Antiviral Drugs Segment by Type in 2021
    Figure 2. Novel Antiviral Drugs Segment by Application in 2021
    Figure 3. Global Novel Antiviral Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Novel Antiviral Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Novel Antiviral Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Novel Antiviral Drugs Revenue in 2021
    Figure 8. By Type - Global Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 12. US Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 24. China Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Novel Antiviral Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Novel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Holding AG Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. GlaxoSmithKline Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bristol-Myers Squibb Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AbbVie Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Johnson & Johnson Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck & Co Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Dr Reddy’s Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Gilead Sciences Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Aurobindo Pharma Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Cipla Novel Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)